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Any cell to become a cancer cell has to acquire a list of competences being genome instability one of the 
new generation hallmarks. Genomic instability of tumors is related to mutations in some or many DNA repair 
genes so that increases the probability to accumulate mutations. 
 
 
 
 
 
 
 
 
 
 
 
Cancer stem cells with genetic instability can be considered as ‘the best vehicle with the best engine’ for 
tumor progression because they preserve its stemness capacity giving rise to all cell types found in tumors. 
 
Telomerase loss generates karyotype instability, amplification and deletion of chromosomic fragments. It 
exists a balance between healthy and disease and it is closely related with telomere length.  
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REFERENCES 
Genomic instability is the natural tendency of genomes to undergo alterations under 
physiological conditions. It refers to an elevated spontaneous or induced mutation 
rate in cells.  
 
Genomic instability is considered a key endogenous mechanism for accumulation of 
mutations, and therefore, it has been proposed as an engine of tumorigenesis. 
 
Genome stability is crucial both to maintain cellular homeostasis as to 
ensure genetic continuity during cell proliferation and reproduction of 
multicellular organisms.  
 
Genome maintenance also includes a complex telomere-processing 
machinery and guards the integrity of mitochondrial DNA. 
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The main role of DNA repair is to allow the genetic information to 
be replicated faithfully and to be transcribed efficiently. Some types 
of damage escape detection by repair pathways and the lesions may 
accumulate. 
 
There are some human genetic diseases caused by the alteration of 
various genes involved in repair mechanisms (e.g. xeroderma 
pigmentosum, Cockayne syndrome, Fanconi anemia). 
Chromosomal instability (CIN) 
 
Microsatellite instability (MSI) 
Genomic instability happens during normal aging and its increase must 
accelerate aging and contrary, its decrease must delay the age-related 
signs, increasing the lifespan. 
 
Aging triggers progressively the activation of INK4a/ARF locus which 
also induces senescence.  
 
In aged organisms, the cellular replacement system (removing 
senescent cells) may become ineffective or can deplete the 
regenerative capacity of stem cells, producing the accumulation of 
senescent cells and the loss of tissue homeostasis that can contribute 
to aging. 
Changes can arise spontaneously during the basic processes of cellular metabolism 
due to DNA repair errors, recombination and replication errors or due to the action of 
metabolic intermediates with reactive capacity.  
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CONCLUSIONS 
TWO SIDES OF THE DNA-DAMAGE 
PROBLEM 
 Face cancer as a chronic disease enabling a long-term management of the disease. Metastatic patients cannot be cured but can be controlled over the time. 
 
 Despite the fact that the underlying mechanisms that link cancer and aging are largely unknown, these remarkable cellular events are two sides of the DNA-
damage problem. 
 
 Genomic instability plays a crucial role in the regulation of age-related diseases and also in aging process. 
 
 DNA damage and mainly genomic instability trigger the deregulated events in cancer, showing some of the differences between hereditary and sporadic cancers.  
 
 Genomic instability drives human genome evolution, both in healthy and disease states. 
 
 There are still no answers that explain what drives initial genomic instability and its continued progression. 
 
 Is genome instability a cause or a consequence? 
FUTURE PERSPECTIVES 
 Create stem cells and mice models of genomic instability generated by 
CRISPR/Cas9 technology introducing DBSs or single-nucleotide changes into 
the genome mimicking human tumors.  
 
 Develop specific cancer chemoprevention to provide anti-cancer and 
anti-aging benefits using natural, synthetic or biological agents to delay 
initial steps of aging and to decrease the risk of inherited cancer. 
 
 Study of cancer and aging resistant animal models.  
 
 Identify genes that protect against cancer from long-lived organisms 
(C.elegans, turtles, naked-mole rats, bowhead whale) by GWAS. 
 
 Understand genes and processes used to protect facing cancer and 
aging. 
 
 Try to identify the genetic factors responsible for the derepression of the 
INK4a/ARF locus during cancer and aging  through functional genomics and 
epigenomics in single-cell analysis. 
 
 Gene therapy as an approach to combat aging delivering telomerase 
(TERT) using viral vectors. 
 
 Analyze the transcriptome under basal p53 conditions because of its 
relevance for aging protection. 
 
 Improve computational analysis of genome-wide sequencing data of DNA 
damage sites and generate tools to analyze huge amounts of data sets of 
tumor genomes from several consortia as The Cancer Genome Atlas (NIH). 
 
